IPO Synopsis

An Initial Public Offering is an opportunity for investors to take part in the growth of a company. It is always better to be in the first batch of investors. The shares offered by the company get listed on the stock exchanges and can be bought and sold by investors.

Login to APPLY
Windlas Biotech Ltd
Registered Office: 40/1 Mohabewala Industrial,Area , Dehradun - 248110 , Uttarakhand , India.
Phone : 91-135-6608000   Fax:
Email :  grievance@windlasbiotech.com  
Website :  www.windlasbiotech.com
Initial Public Offer of 8,729,023* equity shares of face value of (Rs)5 each ("equity shares") of Windlas Biotech Limited ("company" (Rs)455 per equity share) aggregating to (Rs)401.54 Crores (the "offer") comprising a fresh issue of 3,586,956* equity shares aggregating to (Rs)165 Crores (the "fresh issue") and an offer for sale of 5,142,067* equity shares, comprising of 1,136,000* equity shares aggregating to (Rs)52.26* Crores by Vimla Windlass (the "individual selling shareholder") and 4,006,067* equity shares aggregating to (Rs)184.28* Crores by Tano India Private Equity Fund II (the "investor selling shareholder", and collectively with the individual selling shareholder, the "selling shareholders", and such equity shares, the "offered shares") aggregating to (Rs)236.54 Crores (the "offer for sale). The offer constitutes 40.05% of the post-offer paid-up equity share capital of the Company. The face value of equity shares is (Rs)5 each. The offer price is (Rs)460 per equity share and is 92 times the face value of the equity shares. *subject to finalisation of the basis of allotment.

Issue Money Payable On
Opens On Closes On Application Allotment
04-Aug-21 06-Aug-21 (Rs)460.00-0.00 (Rs)0.00-0.00
Minimum Application for shares in Nos :30  Further Multiples of :30

  (Rs Cr) Lead Managers to the Issue
Project Cost 165.00
DAM Capital Advisors Ltd
Project Financed through Current Offer 401.54  
Post Issue Equity Share Capital 10.90  
Issue Price (Rs)460.00  
 
Projects
Purchase of Equipment required for (i) Capacity Expansion of the existing facility at the Dehradun Plant-IV and (II) Addition of Injectables Dosage Capability at the existing facility at Dehradun Plant - IIRepayment/Prepayment of certain of the Borrowings
Funding Incremental Working Capital Requirements of the CompanyGeneral Corporate Purposes
Promoted By
Ashok Kumar Windlass  
Hitesh Windlass  
Manoj Kumar Windlass  
Listing At
BSE 
NSE 
Registrar to the Issue
Link Intime India Pvt Ltd